MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Natural History of Sialidosis Type I: A Prospective Longitudinal Follow-Up Study of Clinical and Electrophysiological Markers

    BY. Gu, YC. Kuo, HW. Hsueh, SP. Fan, CW. Lin, CY. Chien, TK. Lin, MY. Lan, YY. Chang, NC. Lee, YH. Chien, WL. Hwu, CH. Lin (Taipei, Taiwan)

    Objective: We performed a prospective analysis to determine the natural history as well as changes of electrophysiological markers in a cohort of Sialidosis type I.…
  • 2026 International Congress

    Clinical and Genetic Profile of the ACTIVATE Population: A Phase 2 Trial of BIA 28-6156 in GBA-PD

    JJF. Ferreira, RC. Costa, RBM. Bouça-Machado, FRP. Pereira, GC. Cordeiro, TF. Fonseca, MF. Fonseca, DR. Ramos, AG. Guimarães, JH. Holenz (Lisboa, Portugal)

    Objective: To characterize the patient population enrolled in the ACTIVATE study, a Phase 2 multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy, safety, tolerability, pharmacodynamics,…
  • 2026 International Congress

    Basal Ganglia Hypointensity Associated with Glucose Transporter Type 1 Deficiency Syndrome (GLUT1-DS)

    C. Jiménez Clopés, Y. Estrella Domínguez, J. Balsa Vázquez, A. Rojo Sebastián (Alcalá de Henares, Madrid, Spain)

    Objective: To present a new case of glucose transporter type 1 deficiency syndrome (GLUT1-DS) diagnosed in adulthood and to describe the associated radiological findings. Background:…
  • 2026 International Congress

    Dopamine Receptor Blocking Drug Exposure is Associated with Parkinson’s Disease

    L. Neilson, R. Carnahan, V. Kijewski, S. Duffy, G. Scott, N. Narayanan, J. Simmering (Iowa City, USA)

    Objective: To test the hypothesis that dopamine receptor blocking agents (DRBAs) contribute to the later diagnosis of Parkinson’s disease (PD). Background: Recent evidence suggests that…
  • 2026 International Congress

    Neuroimaging-guided automated optimization of deep brain stimulation in Parkinson’s disease: preliminary results

    G. Imbalzano, C. Ledda, A. Romagnolo, M. Rizzone, L. Lopiano, M. Zibetti (Turin, Italy)

    Objective: To evaluate the clinical impact of an automated neuroimaging-guided optimization algorithm (Illumina™, Boston Scientific) for programming in patients with suboptimal response to subthalamic nucleus…
  • 2026 International Congress

    Increased Pre-Alpha EEG Functional Connectivity Forecasts Future Cognitive Decline in Parkinson’s Disease

    A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, N. Pat, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To evaluate whether resting-state EEG functional connectivity (rsEEG-FC) forecasts cognitive decline three years later in Parkinson’s disease (PD). Background: Cognitive performance and trajectories of…
  • 2026 International Congress

    Multimodal Gait Analysis Using Video Pose Estimation Deep Learning and Walkway Parameters: Parkinsonism Detection and Phenotyping

    YS. Kim, JH. Yoon, RW. Park, DG. Park (Suwon, Republic of Korea)

    Objective: To develop a multimodal framework fusing frontal-view video pose estimation frame coordinates with pressure-sensitive walkway features for parkinsonism detection, and to discover clinically meaningful…
  • 2026 International Congress

    The ORCHESTRA Study Year 2: Practical Experiences With Foslevodopa/Foscarbidopa Treatment in Advanced Parkinson’s Disease in a Real-World Setting

    T. Warneck, A. Der Plas, P. Schwingenschuh, A. Johansson, M. Simu, M. O’Meara, M. Li, T. Hancko, L. Bergmann, T. Musacchio, M. Südmeyer (Osnabrück, Germany)

    Objective: To describe real-world learnings on the routine practical management of foslevodopa/foscarbidopa (LDp/CDp), a continuous 24-hour subcutaneous infusion therapy for advanced Parkinson’s disease (aPD), using…
  • 2026 International Congress

    Beyond the Brain: Resting Tremor as a Presentation of Cervical Spinal Schwannoma

    T. Abu-Zahra, I. Goldszer (Detroit, USA)

    Objective: Tremor is classically attributed to abnormalities within supraspinal motor circuits, most commonly the cerebellum, thalamus, red nucleus or basal ganglia and rarely considered a…
  • 2026 International Congress

    Automated Video-Based Assessment of Lip Articulation in Parkinson’s Disease

    J. Strelow, T. Thies, I. Rubi-Fessen, M. Barbe, D. Mücke (Cologne, Germany)

    Objective: To investigate whether automated video-based analysis of lip articulation can capture speech-relevant changes in the orofacial system in Parkinson’s disease (PD) and to determine…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley